Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.890
-0.110 (-3.67%)
At close: Jan 22, 2026, 4:00 PM EST
2.770
-0.120 (-4.15%)
After-hours: Jan 22, 2026, 7:33 PM EST
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $6.45 million as of January 22, 2026. Its market cap has increased by 95.45% in one year.
Market Cap
6.45M
Enterprise Value
4.51M
1-Year Change
95.45%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $6.45M, a decrease of -91.55%. That is a compound annual growth rate of -11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 6.70M | -6.94% |
| Dec 31, 2025 | 7.20M | 132.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
| Sep 22, 2006 | 76.30M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Green Med Solution | 7.17M |
| Silexion Therapeutics | 7.00M |
| Creative Medical Technology Holdings | 6.92M |
| Synlogic | 6.55M |
| Genprex | 6.54M |
| Purple Biotech | 6.47M |
| Theriva Biologics | 6.45M |
| Indaptus Therapeutics | 6.26M |